AI Verdict
LDOS has stronger fundamentals based on our AI analysis.
LDOS vs LCTX Fundamental Comparison
| Metric | LDOS | LCTX |
|---|---|---|
| Revenue | $17.2B | $14.6M |
| Net Income | $1.4B | $-63.5M |
| Net Margin | 8.4% | -436.5% |
| ROE | 29.5% | -142.6% |
| ROA | 10.7% | -56.4% |
| Current Ratio | 1.70x | 5.20x |
| Debt/Equity | 0.94x | 0.00x |
| EPS | $11.14 | $-0.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LDOS vs LCTX: Frequently Asked Questions
Is LDOS or LCTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LDOS has stronger fundamentals. LDOS is rated HOLD (78% confidence) while LCTX is rated SELL (88% confidence). This is not investment advice.
How does LDOS compare to LCTX fundamentally?
Leidos Holdings, Inc. has ROE of 29.5% vs Lineage Cell Therapeutics, Inc.'s -142.6%. Net margins are 8.4% vs -436.5% respectively.
Which stock pays higher dividends, LDOS or LCTX?
LDOS has a dividend yield of N/A or no dividend while LCTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LDOS or LCTX for long term?
For long-term investing, consider that LDOS has HOLD rating with 78% confidence, while LCTX has SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LDOS vs LCTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LDOS vs LCTX, the AI consensus favors LDOS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.